CENSIMLIS Trademark

Trademark Overview

On Friday, July 24, 2020, a trademark application was filed for CENSIMLIS with the United States Patent and Trademark Office. The USPTO has given the CENSIMLIS trademark a serial number of 90071426. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2023. This trademark is owned by Biogen MA Inc.. The CENSIMLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations
censimlis

General Information

Serial Number90071426
Word MarkCENSIMLIS
Filing DateFriday, July 24, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiogen MA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameBiogen MA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, February 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2023SOU EXTENSION 4 GRANTED
Wednesday, February 15, 2023SOU EXTENSION 4 FILED
Wednesday, February 15, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2022SOU EXTENSION 3 GRANTED
Thursday, July 14, 2022SOU EXTENSION 3 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 9, 2022SOU EXTENSION 2 FILED
Wednesday, February 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 28, 2021SOU EXTENSION 1 GRANTED
Wednesday, July 28, 2021SOU EXTENSION 1 FILED
Wednesday, July 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 10, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 28, 2020NEW APPLICATION ENTERED

Related Keywords

censimlis pharmaceutical preparations conditions ophthalmologic diseases treatment disorders